AI-generated analysis. Always verify with the original filing.
Aptose Biosciences issued a press release announcing that Glass Lewis recommends shareholders vote 'FOR' the plan of arrangement under which Hanmi Pharmaceutical and its subsidiary will acquire all outstanding common shares not owned by them, and 'FOR' the continuance to Alberta. The reconvened special meeting is March 31, 2026, with proxy deadline March 27, 2026.
Event Type
Disclosure
Voluntary
Variant
8-K
. Regulation FD Disclosure. On March 23, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated her
. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated March 23, 2026 104 Cover Page Interactive Data File (embed